3/18
03:16 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $58.00 price target on the stock, up previously from $51.00.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $58.00 price target on the stock, up previously from $51.00.
3/13
08:31 am
crbp
Rating for CRBP
Low
Report
Rating for CRBP
3/13
08:31 am
crbp
Rating for CRBP
Low
Report
Rating for CRBP
3/6
08:16 am
crbp
Rating for CRBP
Medium
Report
Rating for CRBP
3/6
08:16 am
crbp
Rating for CRBP
Medium
Report
Rating for CRBP
1/29
01:39 pm
crbp
Rating for CRBP
High
Report
Rating for CRBP
1/29
01:39 pm
crbp
Rating for CRBP
High
Report
Rating for CRBP